WeVote
Log In

Bill

JA

Bill

HB 4544

Health: pharmaceuticals; prescription drug cost and affordability review act; create. Creates new act.

2025-2026 Regular Session Introduced by Joey Andrews and 35 co-sponsors

Michigan establishes new prescription drug cost and affordability review act to examine pharmaceutical pricing and improve medication access for residents.

bill electronically reproduced 06/03/2025
#health:pharmaceuticals #stateagencies(existing):boardsandcommissions #stateagencies(existing):insuranceandfinancialservices
0
WeVote Research Nonpartisan
Bill Summary · HB 4544

Legislative bill overview

HB 4544 establishes a new statutory framework in Michigan to review and address prescription drug costs and affordability. The bill creates mechanisms for analyzing pharmaceutical pricing practices and their impact on residents' access to medications. This is foundational legislation that sets up the structure for future drug cost regulation and oversight.

Why is this important

Prescription drug costs are a major healthcare expense for Michigan residents, affecting both individual budgets and state Medicaid expenditures. Creating a formal review and affordability framework could lead to policy interventions that increase medication access, reduce out-of-pocket costs, or improve transparency in drug pricing. Without more detail on specific mechanisms, the real-world impact depends heavily on what enforcement and regulatory tools the final bill includes.

Potential points of contention

  • Pharmaceutical industry opposition: Drug manufacturers typically resist state-level price controls or cost review requirements, citing impacts on innovation and research investment
  • Implementation costs and scope: Determining which drugs are reviewed, what metrics define "affordability," and agency resource requirements could be contentious among legislators
  • Tension with federal authority: States have limited power over drug pricing under current federal law; the bill's legal viability and relationship to FDA/federal programs may face legal or administrative challenges

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.